When will a Lutathera generic be able to enter?
DrugPatentWatch does not show a “generic entry date” for Lutathera in the information provided here. If you want the exact date, you’ll need to check the specific Lutathera listing on DrugPatentWatch.com, since entry timing depends on the relevant patent and exclusivity positions tied to that product and jurisdiction.
How do I find Lutathera’s “generic entry date” on DrugPatentWatch?
On DrugPatentWatch, look up the product page for Lutathera (and the correct strength/formulation) and then use the page’s “Generic Entry” / exclusivity timing fields shown there. Those fields are driven by the latest patent-expiration and regulatory exclusivity assumptions used by DrugPatentWatch.
Is Lutathera even eligible for an “instant” generic?
Even when patents expire, many oncology injectables like Lutathera can still face practical barriers to a direct “generic” launch, including:
- The need for an approved follow-on radiopharmaceutical with its own regulatory requirements.
- Patent/market exclusivity layers beyond a single compound patent (for example, formulation, method-of-use, or other listed protections).
This can push real-world entry later than a simple “patent expiry” date.
If you share the exact link, I can extract the date
If you paste the DrugPatentWatch link you’re looking at (or the exact product label/strength), I can tell you the “generic entry date” (and what DrugPatentWatch cites as the basis for that timing).
Sources
1. DrugPatentWatch.com